#JPM2020 is right around the corner! The #Kognitic team is excited to hear from numerous industry leaders what is next for the pharma industry, including keynote speaker Emma Walmsley, CEO at #GlaxoSmithKline! As GSK is currently developing assets across almost 50 cancer indications, she will undoubtedly have great insights to share.

See Kognitic’s bullseye view below for more detail about GSK’s oncology assets!

#Oncology #Cancer #AI #Insights #StartupHealth #GSK #Pipeline